Roger A. Goldberg, MD, MBA
Show Description +
Roger Goldberg, MD, MBA, details results from a post hoc analysis of the RISE/RIDE extension study. Dr. Goldberg asks what happened when patients no longer maintained aggressive treatment for DR, and finds data illustrating the relationship between injection frequency and disease severity.
Posted: 7/11/2019
Roger A. Goldberg, MD, MBA
Roger Goldberg, MD, MBA, details results from a post hoc analysis of the RISE/RIDE extension study. Dr. Goldberg asks what happened when patients no longer maintained aggressive treatment for DR, and finds data illustrating the relationship between injection frequency and disease severity.
Posted: 7/11/2019
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2019.
Please log in to leave a comment.